Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

venturebeat.com - VB Staff - Report: Third-party attackers have breached 44% of health care orgs
Report: Third-party attackers have breached 44% of health care orgs
VentureBeat

A report by critical access management leader SecureLink reveals that, in the last 12 months, 44% of health care organizations have experienced a data breach caused by a third party. Developed in partnership with Ponemon Institute, the report…

medcitynews.com - Anuja Vaidya - Joining forces can benefit both patients and pharma companies
Joining forces can benefit both patients and pharma companies
MedCity News

Facilitating a dialogue between patients and pharmaceutical companies can not only help the patients feel heard but also improve pharma marketing and product development. That's according to Jack Barrette, chief innovation officer at Health Union…

globenewswire.com - Visiongain Ltd - Global Pharma Wholesale and Distribution Market is projected to grow at a CAGR of 5.7% By 2031: Visiongain Research Inc
Global Pharma Wholesale and Distribution Market is projected to grow at a CAGR of 5.7% By 2031: Visiongain Research Inc
GlobeNewswire

Visiongain has published a new report entitled the Pharma Wholesale and Distribution Market Report 2021-2031. It includes profiles of Pharma Wholesale and Distribution and Forecasts Market Segment by Type {Full-Line Wholesalers (FLWs), Short-Line…

statnews.com - Most pharma money went to Dems holding up drug-pricing reform
Most pharma money went to Dems holding up drug-pricing reform
STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online calls and deadlines has, of course, returned. To cope, yes, we are firing up…

reuters.com - Ludwig Burger - Novartis says may divest generic drugs unit Sandoz
Novartis says may divest generic drugs unit Sandoz
Reuters

Oct 26 (Reuters) - Novartis (NOVN.S) on Tuesday raised the prospect of divesting its generic drugs unit Sandoz and lifted its peak revenue estimate for its two best-selling pharmaceuticals. 'Novartis has commenced a strategic review of the Sandoz…

forbes.com - Diana Tsai - This Is No Ordinary Unicorn, This Is A Good Unicorn: How NotCo Is Saving The Planet By Making Plants Taste Like Meat
This Is No Ordinary Unicorn, This Is A Good Unicorn: How NotCo Is Saving The Planet By Making Plants Taste Like Meat
Forbes

Matias Muchnick, cofounder and CEO of NotCo, shares incredible insights about how he built NotCo into a $1.5B company, got Jeff Bezos to invest in 3 days, and ultimately, built not just an ordinary Unicorn, but a Good Unicorn. What's a Good…

livemint.com - Ujjval Jauhari - Q2 growth helps Gland Pharma but margins disappoint
Q2 growth helps Gland Pharma but margins disappoint
mint

Gland Pharma Ltd's September quarter performance was mixed. Strong growth across geographies was a cheer but disappointment on the margin front was a dampener. Even so, shares of the company ended 1% up on Monday amid broad market weakness. Gland…

arstechnica.com - Tim De Chant - 'Uh, no'-Pfizer scientist denies Holmes' claim that Pfizer endorsed Theranos tech
'Uh, no'-Pfizer scientist denies Holmes' claim that Pfizer endorsed Theranos tech
Ars Technica

Theranos founder Elizabeth Holmes told Walgreens executives in an email that pharma giant Pfizer had completed its “own technical validation' of Theranos, jurors in Holmes' criminal trial heard Friday. As if to support that claim, Holmes…

theglobeandmail.com - Phil Dabo, MFin - Twenty U.S. growth stocks with high reinvestment rates and earnings momentum
Twenty U.S. growth stocks with high reinvestment rates and earnings momentum
The Globe and Mail

Please log in to bookmark this story. Create Free Account U.S. growth stocks with fundamentally higher reinvestment rates and earnings momentum. The S&P 1500 Pure Growth index has generated a 41.2-per-cent total return over the past year, as of…

bloomberg.com - Naomi Kresge - Novartis May Spin Off or Sell Ailing Sandoz Generics Unit
Novartis May Spin Off or Sell Ailing Sandoz Generics Unit
Bloomberg

Drugmaker will consider Sandoz options including separation Novartis CEO says it's right moment to look at unit's future Novartis AG may spin off or sell its Sandoz generic-drug unit after it consistently failed to meet expectations, with U.S.

thehindu.com - Adya Sharma - Markets of tomorrow
Markets of tomorrow
The Hindu

Education With the increasing demand for goods and services, the rural market is growing at the rate of 15%. | Photo Credit: Rajesh N. Adya Sharma 26 October 2021 15:24 IST Updated: 26 October 2021 15:24 IST Rural marketing is a booming sector with…

statnews.com - Mark Cuban and an employer's coalition to launch new PBMs
Mark Cuban and an employer's coalition to launch new PBMs
STAT

As Americans grapple with prescription drug costs, two new companies are being launched in hopes of transforming the opaque pharmaceutical supply chain that bedevils employers. The Mark Cuban Cost Plus Drug Company and the Purchaser Business Group…

fool.com.au - Zach Bristow - Creso Pharma (ASX:CPH) share price spikes on bonus options issue
Creso Pharma (ASX:CPH) share price spikes on bonus options issue
The Motley Fool Australia

The Creso Pharma Ltd (ASX: CPH) share price is gaining ground in early trading, currently up around 9% at 12 cents apiece. Creso Pharma shares are on the move as the company released a prospectus today, amid an acquisition that was completed…

hindustantimes.com - HT Brand Studio - The Indian healthcare industry will continue to draw investor attention
The Indian healthcare industry will continue to draw investor attention
Hindustan Times

India's healthcare infrastructure is set for massive growth. By FY 22, the size of India's healthcare infrastructure will reach USD 349.1 billion, growing by 17% on an annual basis, as per the research by “ theIndiawatch.com ”, an…

mb.com.ph - Bernie Cahiles-Magkilat - PEZA approves Israeli-Filipino vaccine manufacturing project
PEZA approves Israeli-Filipino vaccine manufacturing project
Manila Bulletin

Israeli-Filipino joint venture Savepoint Biotek has been approved as manufacturer of oral COVID-19 vaccines with projected annual sales of $180 million from the Philippines and export markets. The Philippine Economic Zone Authority (PEZA) Board has…

Receive a Daily briefing on Pharma Industry News